Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial

詳細情報 詳細情報について

• CRID

  1364233268738172928

• DOI

  10.1016/s2213-2600(18)30181-4

• ISSN

  22132600

• Web Site

  https://api.elsevier.com/content/article/PII:S2213260018301814?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S2213260018301814?httpAccept=text/plain

• データソース種別

  • Crossref